Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaglenastat in Pulmonary Hypertension
NCT07223528Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telaglenastat in pulmonary hypertension (PH). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
telaglenastat
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07223528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07223528.